Evidence map›Paper›PMID 32178315›Full record

ReviewMolecules (Basel, Switzerland)2020

Bioactive Peptides from Walnut Residue Protein.

Xiangyang Li, Manli Guo, Jingtian Chi, Jiangang Ma

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Food chemistry. Molecular sciences · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiangyang LiScience and Technology Department, Hebei Lvlei Agroforestry Technology Co., Ltd. Shijiazhuang 050050, China.
Manli GuoCollege of Food Science and Engineering, Shandong Agricultural University, Taian 271018, China.
Jingtian ChiCollege of Food Science and Engineering, Shandong Agricultural University, Taian 271018, China.
Jiangang MaScience and Technology Department, Hebei Lvlei Agroforestry Technology Co., Ltd. Shijiazhuang 050050, China.

Funding

Key R & D programs in Shandong, PR China 2018YYSP029The "13th Five-Year" national key development program of China 2018YFD0401100 and 2016YDF0401400The National Natural Science Foundation of China 31872889
6 · The paper itself

Abstract

Walnut residue is a kind of high-quality plant protein resource. The bioactive peptide prepared from walnut residue has excellent health care functions such as antioxidation and antihypertensive activity, but at present, walnut residue is often regarded as waste or low value feed, fertilizer and other materials. The uneconomical use of walnut residue has hindered the development of the walnut industry to some extent. Effective utilization of walnut residue protein to develop bioactive peptides and other products is of great significance to realize the comprehensive utilization of walnut residue, improve the added value of by-products, and change the current low utilization rate of walnut residue. In this paper, the preparation, purification and structure identification of walnut protein bioactive peptides are reviewed, and different functional walnut active peptides (WBPs) are introduced. The potential effects of these bioactivities on human health and their different uses in food, medicine and other industries are discussed. The purpose is to provide reference information for the effective utilization of walnut residue resources and the development of walnut industry.

Indexed as

AntioxidantsHumansJuglansPeptidesPlant ExtractsPlant ProteinsAntioxidantsPeptidesPlant ExtractsPlant Proteinsantihypertensive activityantioxidationbioactive peptidepreparationwalnut residue

Identifiers

PMID32178315
PMCPMC7143977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.